Search

everythinglearnresearchcommunity

for

Search:↓

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Deep eutectic solvents are eco-friendly and effective for extracting useful pharmaceutical compounds.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

High levels of prolactin in the blood can be linked to widespread hair loss.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

Low testosterone levels may contribute to female pattern hair loss in men.

Medium-sized particles penetrate hair follicles better than smaller or larger ones, which could improve delivery of skin treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormonal differences affect male pattern baldness.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Platelet-rich plasma helps hair regrowth and improves quality of life in women with hair loss, but minoxidil may be more effective.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Stronger corticosteroids cause more skin damage in hairless dogs, similar to effects in humans.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Minoxidil works better when applied on a damp scalp than a dry one.

Ethosomes improve drug delivery through the skin and show promise for treating male pattern baldness.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Understanding repigmentation mechanisms in vitiligo can improve treatments and patient outcomes.

Topical oligonucleotide therapy targets hair follicles effectively.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.